In the United States, the patent expiring in is subject to reexamination proceedings instituted by a third party. The products sold in international business include not only those developed in the United States, but also those developed by subsidiaries abroad.
Competition in research, both internally and externally sourced, involving the development and the improvement of new and existing products and processes, is particularly significant. The competitive environment requires substantial investments in continuing research and in maintaining sales forces.
Additional information required by this item is incorporated herein by reference to the narrative and tabular descriptions of segments and operating results under: These have both positive and negative impacts on the U.
The costs of human health care have been and continue to be a subject of study, investigation and regulation by governmental agencies and legislative bodies around the world. In Australia, the patent expires in August The Company considers these trademarks in the aggregate to be of material importance in the operation of its businesses.
Medical Devices and Diagnostics The Medical Devices and Diagnostics segment includes a broad range of products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, therapists, hospitals, diagnostic laboratories and clinics.
The Company remains committed to investing in research and development with the aim of delivering high quality and innovative products. Similar trends are also evident in major markets outside of the U.
Investments and activities in some countries outside the United States are subject to higher risks than comparable U. Those proceedings are on-going. These products are marketed to the general public and sold both to retail outlets and distributors throughout the world.
Distribution to these health care professional markets is done both directly and through surgical supply and other distributors. These products are distributed directly to retailers, wholesalers and health care professionals for prescription use.
Competition exists in all product lines without regard to the number and size of the competing companies involved. Seasonality Worldwide sales do not reflect any significant degree of seasonality; however, spending has been heavier in the fourth quarter of each year than in other quarters.
This reflects increased spending decisions, principally for advertising and research and development activity. Seasonality Worldwide sales do not reflect any significant degree of seasonality; however, spending has been heavier in the fourth quarter of each year than in other quarters.
Competition exists in all product lines without regard to the number and size of the competing companies involved. The exercise of broad regulatory powers by the U. Securities and Exchange Commission the "SEC"and any amendments to the foregoing, will be provided without charge to any shareholder submitting a written request to the Secretary at the principal executive offices of the Company or by calling This reflects increased spending decisions, principally for advertising and research and development activity.
Investments and activities in some countries outside the U. Products in this segment are distributed directly to retailers, wholesalers, hospitals and health care professionals for prescription use. Consumer, Pharmaceutical and Medical Devices. In line with the principle of decentralized management, senior management groups at U.
Where there are exceptions, the temporary unavailability of those raw materials would not likely have a material adverse effect on the financial results of the Company. In the United States, the latest patent expires in September Medical Devices The Medical Devices previously referred to as Medical Devices and Diagnostics segment includes a broad range of products used in the orthopaedic, surgical care, specialty surgery, cardiovascular care, diagnostics, diabetes care, and vision care markets, which are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, and clinics.
This Committee oversees and coordinates the activities of the Consumer, Pharmaceutical and Medical Devices previously referred to as Medical Devices and Diagnostics business segments.Innovation is at the heart of what we do as a company, and as these stories show, Johnson & Johnson unveiled forward-thinking solutions across its portfolio of operating companies and innovation centers throughout the world in Annual Meeting Materials; Stock Information; Corporate Governance; Whether you are a member of the Board, a senior leader, or starting your first day as an employee of Johnson Controls, we all come to work with the understanding that integrity is the cornerstone of our success, and it is a fundamental element to effective Corporate.
Annual Meeting Materials; Stock Information; Corporate Governance; IR Resources; Insights; Corporate Sustainability; Global Capabilities; Adient SEC Filings; Financial Reports; Johnson Controls SEC Filings; Adient SEC Filings; Financial Reports; Johnson Controls SEC Filings.
Register for email alerts. Buildings. Air Systems; Building. Corporate Reports; Products. Consumer Products; Medical Devices; Pharmaceutical Products the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc.
Contact Us with any questions or search Annual Meeting Materials. Year in Review Online. 11 rows · Exhibit 21 - Subsidiaries, Form K for SEC filings represent the financial reports and statements filed with the Securities and Exchange Commission by Johnson & Johnson.
Amendments to the Excess Benefit Plan of Johnson & Johnson and Affiliated Companies effective as of January 1, — Incorporated herein by reference to Exhibit 10(r) of the Registrant’s Form K Annual Report for the year ended December 28, *.Download